BiotechTube
Home/Proniras/Lindsay Rayle
LR

Lindsay Rayle

Vice President of Finance

Proniras

Therapeutic Areas

Substance Use DisordersCentral Nervous System (CNS) Disorders

Proniras Pipeline

DrugIndicationPhase
Tezampanel (PRN-001-01)Opioid Use Disorder (Opiate Withdrawal Syndrome)Phase 1

Leadership Team at Proniras

TQ
Thong Q. Le
President & CEO
CT
Christopher Toombs, PhD, DABT
Cofounder & Chief Scientific Officer
AC
Andrew Chambers, MD
Addiction Psychiatry PI
View full Proniras profile